As a prominent representative of international Chinese businessmen in Southern California, Ms. Wang Lihong has made remarkable achievements in the field of business and public welfare, and has become an outstanding female entrepreneur and entrepreneurial pioneer in the Chinese community. She has demonstrated outstanding leadership in corporate management and business innovation, and actively promoted economic and cultural exchanges between China and the United States, making important contributions to the development of bilateral relations. She has received the President's Award for Lifetime Achievement in the United States, the Chinese American Lady Award, the Top Ten Asian Women Award and the Hong Kong Corporate Responsibility Award. Ms. Wang Lihong is a public-spirited woman dedicated to social welfare and community development. In the business sector, she has incubated several technology industry projects and medical biotechnology companies, leading several organizations to become industry leaders, driving innovation in regenerative medicine and immune cell therapy. Her story has inspired countless young people of Chinese descent to pursue excellence and achieve their dreams on the global stag.

Dr. Li is a partner and director of medical education at Boomerang Healthcare and a visiting clinical professor at Stanford University's Pain Center. He specializes in pain management and regenerative medicine for clients including professional athletes and Silicon Valley executives. Dr. Li has published more than 20 articles in international journals and has spoken at several international conferences. He has participated in several clinical trials and has been featured in several media outlets. He is the Chief Medical Officer of iHealth Frontier, dedicated to optimizing the administration of healthcare in the United States and serves as Vice President of the World Association of Chinese Physicians. Dr. Li has a medical background from Zhejiang University School of Medicine and Peking Union Medical University, as well as a Ph.D. in pharmacology from the University of Florida. He completed his residency and specialist training in pain at Harvard and Stanford Universities and serves as an independent director of EDOC Acquisition Corp.

Jack X Lee graduated from the Department of Industrial Enterprise Management, Fuzhou University. He has long focused on commercial operations and accumulated rich experience in enterprise formation, operation and listing. Previously held marketing positions at the top stem cell bank in the United States. Together with UCLA's expert professors, clinicians, scientists, and laboratories focused on Cell therapy and gene editing, they founded the Beverly Hills Stem Cell Institute Group. The group, which integrates cancer hospitals and plastic hospitals, has developed stem cell targeting technology and is committed to achieving precision medicine in the true sense of the word in the foreseeable future through the application of AI technology to prevent and cure diseases for the benefit of humanity.